{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Bridgewater",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "NDA018859"
        ],
        "brand_name": [
          "VIRAZOLE"
        ],
        "generic_name": [
          "RIBAVIRIN"
        ],
        "manufacturer_name": [
          "Bausch Health US, LLC"
        ],
        "product_ndc": [
          "0187-0007"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "RESPIRATORY (INHALATION)"
        ],
        "substance_name": [
          "RIBAVIRIN"
        ],
        "rxcui": [
          "207406",
          "312818"
        ],
        "spl_id": [
          "a2282c58-67c0-48ac-ae4f-f05e98d6f3c0"
        ],
        "spl_set_id": [
          "adf16e64-345f-469a-b987-3fbdd17e0ac2"
        ],
        "package_ndc": [
          "0187-0007-14",
          "0187-0007-01"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175459",
          "N0000175466"
        ],
        "pharm_class_epc": [
          "Nucleoside Analog Antiviral [EPC]"
        ],
        "unii": [
          "49717AWG6K"
        ]
      },
      "product_type": "Drugs",
      "event_id": "70123",
      "recalling_firm": "Valeant Pharmaceuticals North America LLC",
      "address_1": "400 Somerset Corporate Blvd",
      "address_2": "N/A",
      "postal_code": "08807",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide and Australia",
      "recall_number": "D-0379-2015",
      "product_description": "Virazole (Ribavirin for Inhalation Solution, USP), Sterile Lyophilized For Administration by Aerosol Inhalation Only, Rx only, Contents: Four  6 g vials, 100 mL, Distributed by: Valeant Pharmaceuticals North America, Bridgewater, NJ 08807 USA, NDC 0187-0007-14.",
      "product_quantity": "2,428 vials",
      "reason_for_recall": "Non-Sterility: Valeant's laboratory observed a positive microbial contamination of Virazole lot 340353F, during testing at the 12 month stability pull.",
      "recall_initiation_date": "20141231",
      "center_classification_date": "20150122",
      "termination_date": "20171004",
      "report_date": "20150128",
      "code_info": "Lot #: 340353F, Exp 10/2018"
    }
  ]
}